Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001782999-24-000004
Filing Date
2024-08-28
Accepted
2024-08-28 07:29:31
Documents
93
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 6-K ptv-20240630.htm   iXBRL 6-K 164564
2 EX-99.1 a991pressrelease.htm EX-99.1 64228
3 EX-99.2 a992interimmanagementrepor.htm EX-99.2 179230
4 EX-99.3 ptv-20240630_d2.htm   iXBRL EX-99.3 903005
10 ptv-20240630_g1.jpg GRAPHIC 2558
  Complete submission text file 0001782999-24-000004.txt   7286090

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptv-20240630.xsd EX-101.SCH 95226
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptv-20240630_cal.xml EX-101.CAL 85671
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptv-20240630_def.xml EX-101.DEF 373699
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ptv-20240630_lab.xml EX-101.LAB 675672
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptv-20240630_pre.xml EX-101.PRE 524581
96 EXTRACTED XBRL INSTANCE DOCUMENT ptv-20240630_htm.xml XML 1151335
Mailing Address 6 TIDE STREET SUITE 400 BOSTON MA 02210
Business Address 6 TIDE STREET SUITE 400 BOSTON MA 02210 617-482-2333
PureTech Health plc (Filer) CIK: 0001782999 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39670 | Film No.: 241251060
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)